国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Chromobacterium violaceum tRNA (Ile)-lysidine synthase (tilS) CSB-YP752467CKA
CSB-EP752467CKA
CSB-BP752467CKA
CSB-MP752467CKA
CSB-EP752467CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Lipoyl synthase (lipA) CSB-YP752468CKA
CSB-EP752468CKA
CSB-BP752468CKA
CSB-MP752468CKA
CSB-EP752468CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum ADP-L-glycero-D-manno-heptose-6-epimerase (hldD) CSB-YP752469CKA
CSB-EP752469CKA
CSB-BP752469CKA
CSB-MP752469CKA
CSB-EP752469CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum NADH pyrophosphatase (nudC) CSB-YP752470CKA
CSB-EP752470CKA
CSB-BP752470CKA
CSB-MP752470CKA
CSB-EP752470CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Taurine import ATP-binding protein TauB (tauB) CSB-YP752471CKA
CSB-EP752471CKA
CSB-BP752471CKA
CSB-MP752471CKA
CSB-EP752471CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum NADH-quinone oxidoreductase subunit B 2 (nuoB2) CSB-YP752472CKA
CSB-EP752472CKA
CSB-BP752472CKA
CSB-MP752472CKA
CSB-EP752472CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Valine--tRNA ligase (valS), partial CSB-YP752473CKA
CSB-EP752473CKA
CSB-BP752473CKA
CSB-MP752473CKA
CSB-EP752473CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Anhydro-N-acetylmuramic acid kinase (anmK) CSB-YP752474CKA
CSB-EP752474CKA
CSB-BP752474CKA
CSB-MP752474CKA
CSB-EP752474CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Glucose-6-phosphate isomerase 2 (pgi2), partial CSB-YP752475CKA
CSB-EP752475CKA
CSB-BP752475CKA
CSB-MP752475CKA
CSB-EP752475CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Phosphoserine aminotransferase (serC) CSB-YP752476CKA
CSB-EP752476CKA
CSB-BP752476CKA
CSB-MP752476CKA
CSB-EP752476CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Uridylate kinase (pyrH) CSB-YP752477CKA
CSB-EP752477CKA
CSB-BP752477CKA
CSB-MP752477CKA
CSB-EP752477CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum 3-isopropylmalate dehydratase small subunit 1 (leuD1) CSB-YP752478CKA
CSB-EP752478CKA
CSB-BP752478CKA
CSB-MP752478CKA
CSB-EP752478CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Elongation factor 4 (lepA), partial CSB-YP752479CKA
CSB-EP752479CKA
CSB-BP752479CKA
CSB-MP752479CKA
CSB-EP752479CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC (mnmC), partial CSB-YP752480CKA
CSB-EP752480CKA
CSB-BP752480CKA
CSB-MP752480CKA
CSB-EP752480CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Translation initiation factor IF-1 1 (infA1) CSB-YP752481CKA
CSB-EP752481CKA
CSB-BP752481CKA
CSB-MP752481CKA
CSB-EP752481CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Leucyl/phenylalanyl-tRNA--protein transferase (aat) CSB-YP752482CKA
CSB-EP752482CKA
CSB-BP752482CKA
CSB-MP752482CKA
CSB-EP752482CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Flagellar P-ring protein 1 (flgI1) CSB-YP752483CKA
CSB-EP752483CKA
CSB-BP752483CKA
CSB-MP752483CKA
CSB-EP752483CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Protein FdhD homolog (fdhD) CSB-YP752484CKA
CSB-EP752484CKA
CSB-BP752484CKA
CSB-MP752484CKA
CSB-EP752484CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Alanine--tRNA ligase (alaS), partial CSB-YP752485CKA
CSB-EP752485CKA
CSB-BP752485CKA
CSB-MP752485CKA
CSB-EP752485CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Acetate kinase (ackA) CSB-YP752486CKA
CSB-EP752486CKA
CSB-BP752486CKA
CSB-MP752486CKA
CSB-EP752486CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>